Your browser doesn't support javascript.
loading
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.
Ferment, B; Lambert, J; Caillot, D; Lafon, I; Karlin, L; Lazareth, A; Touzeau, C; Leleu, X; Moya, N; Harel, S; Perrot, A; Bories, P; Vincent, L; Lamure, S; Mohty, M; Malard, F; Manier, S; Yakoub-Agha, I; Schiano De Colella, J-M; Brisou, G; Talbot, A; Decaux, O; Houot, R; Le Gouill, S; Bigot, N; Facon, T; Corre, J; Moreau, P; Arnulf, B.
Afiliação
  • Ferment B; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.
  • Lambert J; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.
  • Caillot D; Biostatistics Department, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.
  • Lafon I; Department of Hematology, Institut de Cancérologie de Bourgogne (ICB), Dijon, France.
  • Karlin L; Department of Hematology, Dijon University Hospital, Dijon, France.
  • Lazareth A; Department of Hematology, Institut de Cancérologie de Bourgogne (ICB), Dijon, France.
  • Touzeau C; Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Benite, France.
  • Leleu X; Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Benite, France.
  • Moya N; Department of Hematology, Nantes University Hospital, Nantes, France.
  • Harel S; Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France.
  • Perrot A; Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France.
  • Bories P; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.
  • Vincent L; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.
  • Lamure S; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France.
  • Mohty M; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France.
  • Malard F; Department of Hematology, Montpellier University Hospital, Montpellier, France.
  • Manier S; Department of Hematology, Centre Léon Bérard, Lyon, France.
  • Yakoub-Agha I; Saint-Antoine Hospital, INSERM UMRs 938, Sorbonne University, Paris, France.
  • Schiano De Colella JM; Saint-Antoine Hospital, INSERM UMRs 938, Sorbonne University, Paris, France.
  • Brisou G; Department of Hematology, Lille Regional and University Hospital, Lille, France.
  • Talbot A; Department of Hematology, Lille Regional and University Hospital, Lille, France.
  • Decaux O; Department of Hematology, Institut Paoli Calmettes, Marseille, France.
  • Houot R; Department of Hematology, Institut Paoli Calmettes, Marseille, France.
  • Le Gouill S; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.
  • Bigot N; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.
  • Facon T; Department of Hematology, Rennes University Hospital, Pontchaillou Hospital, Rennes, France.
  • Corre J; Department of Hematology, Rennes University Hospital, Pontchaillou Hospital, Rennes, France.
  • Moreau P; Université Versailles Saint-Quentin, Versailles, France.
  • Arnulf B; Department of Hematology, Institut Curie, Paris, France.
Br J Haematol ; 2024 May 15.
Article em En | MEDLINE | ID: mdl-38747092
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article